| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000259416.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004220133 |
Resistant |
| ENSG00000259416.2 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.002399124 |
Sensitive |
| ENSG00000259416.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.024778422 |
Sensitive |
